Publication:
A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model

dc.contributor.authorÖZCAN, PINAR
dc.contributor.authorCenksoy, PINAR
dc.contributor.authorERDEM, OSMAN AYHAN
dc.contributor.authorSancak, Banu
dc.contributor.authorGursoy, Rifat
dc.date.accessioned2020-12-16T20:59:17Z
dc.date.available2020-12-16T20:59:17Z
dc.date.issued2014-03-01T00:00:00Z
dc.description.abstractObjective: To investigate the effects of VIA receptor antagonist through inhibition of vasopressin-induced, VEGF secretion in an experimental model.
dc.identifier.citationCenksoy C., Cenksoy P., ERDEM O. A. , Sancak B., Gursoy R., -A potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model-, EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.174, ss.86-90, 2014
dc.identifier.doi10.1016/j.ejogrb.2013.12.001
dc.identifier.pubmed24405730
dc.identifier.scopus84894243189
dc.identifier.urihttp://hdl.handle.net/20.500.12645/27706
dc.identifier.wosWOS:000333505500015
dc.titleA potential novel strategy, inhibition of vasopressin-induced VEGF secretion by relcovaptan, for decreasing the incidence of ovarian hyperstimulation syndrome in the hyperstimulated rat model
dc.typeArticle
dspace.entity.typePublication
dspace.relatedentity.typePerson
local.avesis.id663ddce8-c88c-471b-8c29-dd60020efcb1
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
person.identifier.orcid0000-0002-0306-6422
relation.isAuthorOfPublicationa223be34-acbb-4ec3-8217-209ec916f373
relation.isAuthorOfPublication.latestForDiscoverya223be34-acbb-4ec3-8217-209ec916f373

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
p.pdf
Size:
524.41 KB
Format:
Adobe Portable Document Format

Collections